Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
160 USD | -0.80% | -1.59% | +3.23% |
May. 13 | AbbVie, Gilgamesh Pharmaceuticals Partner to Develop Therapies for Psychiatric Disorders | MT |
May. 09 | Medincell: share price rises on resumption of trading | CF |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.23% | 285B | |
+29.90% | 682B | |
+30.35% | 586B | |
-3.70% | 364B | |
+17.71% | 327B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+7.37% | 165B | |
-1.96% | 161B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- Transcript : AbbVie Inc. Presents at Piper Sandler 34th Annual Healthcare Conference, Dec-01-2022 09